Instand-NGS4P is a H2020 funded project for improving cancer patients’ benefit from Next Generation Sequencing (NGS) by developing an integrated and standardized NGS workflow and integrating information from cancer gene testing, pharmacogenetics testing and e-medication in proper presentation to medical doctors to support therapy decision at bedside. The project started in January 2020 and has […]
HELSINKI, Finland. Euformatics, BC Platforms and Oncompass Medicine formed a partnership to bid for the development of standardized oncology workflows for a buyer consortium of seven leading hospitals* based in Central Europe and co-funded by the European Union Grant Agreement n° 874719. The buyer consortium, represented by the Medical University Graz, evaluated all proposals and awarded […]
Study will evaluate whether blood-based testing can inform oncology providers about genetic variations within a patient’s cancer, which may influence choice of treatment based on cancer stage and type SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) a global leader in DNA sequencing and array-based technologies, and Allegheny Health Network (AHN), an integrated health system serving the Western Pennsylvania […]
Alliance Pharma, a US-based Bioanalytical CRO and an Ampersand portfolio company, has agreed to acquire DDS, a UK-based Bioanalytical Business Unit of LGC. KKR will become an equal shareholder in the combined business alongside Ampersand Capital Partners. Backed by Ampersand and KKR, Alliance and DDS plan to expand the company’s geographic reach, broaden its laboratory […]
LONGMONT, Colo. — KromaTiD a single-cell analysis company focused on the research, development, and commercialization of technology solutions for the cell and gene therapy market, announces the launch of KromaTiD Pinpoint FISH™ Probes. This product offering expands on our 10 years of service providing high-resolution assays with superior detection, and robust data, for our client’s large […]
Long-anticipated instrument is compatible with any 5-, 6- or 8-color STR analysis chemistry Madison, WI USA. — Forensics laboratories performing human identification in criminal casework and database cases have a new option for a capillary electrophoresis (CE) instrument to support their workflow. The Spectrum CE System, launched today by Promega, presents a new alternative in […]
Latest addition to Company’s genomic testing services menu delivers rapid results to physicians that inform clinical management and outcomes for critically ill patients WALTHAM, Mass. — PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer Genomics. This addition to the Company’s portfolio of […]
A partnership between two CRISPR pioneers will provide the global scientific community with GMP MAD7™ Nuclease Aldevron®, a global leader in the custom development and manufacture of plasmid DNA, RNA and proteins for the biotech industry, along with Inscripta®, a life science technology company dedicated to making CRISPR-based genome engineering accessible to any research lab, […]
Oxford Nanopore technology will enable the 1000 Genomes Project, spearheaded by researchers at the University of Washington and Seattle Children’s Hospital, to gain greater genomic insights into clinically relevant variants by providing accurate, affordable, scalable and comprehensive information Uncovering new discoveries across the genome Oxford Nanopore sequencing technology is to be used by a group […]
BLIRT SA, a biotech firm specializing in producing high-quality enzymes and reagents used in life sciences and global diagnostics, has changed its ownership structure. International biotech company QIAGEN has acquired over 96% of the shares of BLIRT. “Over recent years, we have intensively grown our business,” said Marian Popinigis, CEO of BLIRT SA. “We have invested, observed […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
